In order to obtain the maximum use of these drugs, we want to give a boost to their use by increasing the knowledge of the SGLT2-i and better understanding the mechanisms of this new class of drugs, highlighting strengths and weaknesses and providing a brief comment on major trials that made Gliflozins a cornerstone in HF therapy. Here, SLC5A2 is linked to hydrops fetalis.